Esorej-L Capsule SR is a combination medication containing Levosulpiride 75mg and Esomeprazole 40mg, formulated to provide effective relief from gastrointestinal disorders. Levosulpiride, a prokinetic and antipsychotic agent, enhances gastrointestinal motility by blocking dopamine receptors, thereby improving gastric emptying and alleviating symptoms such as nausea, vomiting, bloating, and abdominal discomfort often associated with functional dyspepsia and gastroparesis. Esomeprazole, a proton pump inhibitor, reduces gastric acid secretion by inhibiting the H+/K+ ATPase enzyme in the stomach lining, promoting healing of erosive esophagitis, gastroesophageal reflux disease (GERD), and peptic ulcers. The sustained-release formulation of Esorej-L ensures a prolonged therapeutic effect, enhancing patient compliance by maintaining steady plasma levels of both active ingredients. This combination is particularly beneficial in managing conditions where delayed gastric emptying and excessive acid production coexist, offering symptomatic relief and mucosal protection. Esorej-L Capsule SR should be used under medical supervision, with caution advised in patients with known hypersensitivity to either component, and those with pre-existing liver or kidney conditions. It is important to follow prescribed dosages and consult a healthcare professional if symptoms persist or worsen.